Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 3
2010 2
2011 2
2013 2
2014 1
2015 5
2016 3
2017 1
2018 9
2019 12
2020 11
2021 14
2022 12
2023 8
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Nerve sheath tumours.
Robertson JA, Tallantyre EC. Robertson JA, et al. Among authors: tallantyre ec. J Neurol. 2018 Dec;265(12):3034-3035. doi: 10.1007/s00415-018-9098-y. J Neurol. 2018. PMID: 30382390 Free PMC article. No abstract available.
Secondary antibody deficiency in neurology.
Tallantyre EC, Robertson NP, Jolles S. Tallantyre EC, et al. Curr Opin Allergy Clin Immunol. 2018 Dec;18(6):481-488. doi: 10.1097/ACI.0000000000000485. Curr Opin Allergy Clin Immunol. 2018. PMID: 30299398 Review.
Optic neuritis and MOGAD.
Htet ZM, Tallantyre E. Htet ZM, et al. Among authors: tallantyre e. J Neurol. 2023 Jun;270(6):3278-3279. doi: 10.1007/s00415-023-11738-7. Epub 2023 May 8. J Neurol. 2023. PMID: 37154890 No abstract available.
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.
Kodosaki E, Watkins WJ, Loveless S, Kreft KL, Richards A, Anderson V, Hurler L, Robertson NP, Zelek WM, Tallantyre EC. Kodosaki E, et al. Among authors: tallantyre ec. J Neuroinflammation. 2024 Feb 17;21(1):52. doi: 10.1186/s12974-024-03036-4. J Neuroinflammation. 2024. PMID: 38368354 Free PMC article.
Decentralised clinical trials in multiple sclerosis research.
Garjani A, Liu BJ, Allen CM, Gunzler DD, Gerry SW, Planchon SM, das Nair R, Chataway J, Tallantyre EC, Ontaneda D, Evangelou N. Garjani A, et al. Among authors: tallantyre ec. Mult Scler. 2023 Mar;29(3):317-325. doi: 10.1177/13524585221100401. Epub 2022 Jun 23. Mult Scler. 2023. PMID: 35735014 Free PMC article. Review.
Real-world persistence of multiple sclerosis disease-modifying therapies.
Tallantyre EC, Dobson R, Froud JLJ, St John FA, Anderson VM, Arun T, Buckley L, Evangelou N, Ford HL, Galea I, George S, Gray OM, Hibbert AM, Hu M, Hughes SE, Ingram G, Kalra S, Lim CE, Mathews JTM, McDonnell GV, Mescall N, Norris S, Ramsay SJ, Rice CM, Russell MJ, Shawe-Taylor MJ, Williams TE, Harding KE, Robertson NP. Tallantyre EC, et al. Eur J Neurol. 2024 Jul;31(7):e16289. doi: 10.1111/ene.16289. Epub 2024 Apr 3. Eur J Neurol. 2024. PMID: 38567516 Free PMC article.
Rituximab in neurological disease: principles, evidence and practice.
Whittam DH, Tallantyre EC, Jolles S, Huda S, Moots RJ, Kim HJ, Robertson NP, Cree BAC, Jacob A. Whittam DH, et al. Among authors: tallantyre ec. Pract Neurol. 2019 Feb;19(1):5-20. doi: 10.1136/practneurol-2018-001899. Epub 2018 Nov 29. Pract Neurol. 2019. PMID: 30498056 Review.
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.
Roos I, Sharmin S, Malpas C, Ozakbas S, Lechner-Scott J, Hodgkinson S, Alroughani R, Eichau Madueño S, Boz C, van der Walt A, Butzkueven H, Buzzard K, Skibina O, Foschi M, Grand'Maison F, John N, Grammond P, Terzi M, Prévost J, Barnett M, Laureys G, Van Hijfte L, Luis Sanchez-Menoyo J, Blanco Y, Oh J, McCombe P, Ramo Tello C, Soysal A, Prat A, Duquette P, Yamout BI, Khoury S, van Pesch V, Macdonell R, José Sá M, Slee M, Kuhle J, Maimone D, Spitaleri D, Willekens B, Asmi AA, Tallantyre E, Robertson NP, Coles A, L Brown JW, Kalincik T. Roos I, et al. Among authors: tallantyre e. Mult Scler. 2024 Aug;30(9):1163-1175. doi: 10.1177/13524585241267211. Epub 2024 Aug 1. Mult Scler. 2024. PMID: 39087208
Clinical observation during alemtuzumab administration.
Allen CM, Feng JJ, Willis MD, McGinley M, Ontaneda D, Tallantyre EC, Evangelou N. Allen CM, et al. Among authors: tallantyre ec. Mult Scler Relat Disord. 2020 Jan;37:101412. doi: 10.1016/j.msard.2019.101412. Epub 2019 Sep 25. Mult Scler Relat Disord. 2020. PMID: 32172992 No abstract available.
81 results